ENDRA Life Sciences (NDRA) Market Capitalization (2017 - 2026)

ENDRA Life Sciences (NDRA) has reported Market Capitalization for 10 consecutive years, with $8.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization rose 202.71% year-over-year to $8.0 million in Q2 2026; TTM through Jun 2026 was $8.0 million, a 202.71% increase from a year earlier, with the FY2025 full-year figure at $3.6 million, up 181.79% from the prior year.
• Market Capitalization was $8.0 million for Q2 2026 at ENDRA Life Sciences, up from $5.8 million in the prior quarter.
• Over five years, Market Capitalization peaked at $676.6 million in Q3 2022 and troughed at $1.3 million in Q4 2024.
• A 5-year average of $217.9 million and a median of $157.1 million in 2024 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization sank 99.73% in 2024 and soared 202.71% in 2026, its largest moves.
• Over 5 years, Market Capitalization stood at $451.4 million in 2022, then rose by 4.6% to $472.2 million in 2023, then slumped by 99.73% to $1.3 million in 2024, then soared by 181.79% to $3.6 million in 2025, then jumped by 124.23% to $8.0 million in 2026.
• The last three Market Capitalization figures came in at $8.0 million (Q2 2026), $5.8 million (Q1 2026), and $3.6 million (Q4 2025), per Business Quant data.